Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 70.09
-0.04 (-0.06%)
Mar 10, 2026, 10:35 AM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 28,626 | 34,157 | 29,847 | 21,296 | 15,837 | 11,911 | Upgrade
|
| Market Cap Growth | -11.93% | 14.44% | 40.15% | 34.47% | 32.96% | -14.13% | Upgrade
|
| Enterprise Value | 27,942 | 33,473 | 29,272 | 20,670 | 15,360 | 11,446 | Upgrade
|
| Last Close Price | 70.13 | 83.68 | 72.76 | 51.54 | 38.13 | 28.57 | Upgrade
|
| PE Ratio | 27.50 | 32.92 | 36.06 | 38.34 | 55.18 | 65.73 | Upgrade
|
| Forward PE | 19.33 | 28.12 | 28.12 | 28.12 | 28.12 | 28.12 | Upgrade
|
| PS Ratio | 7.75 | 9.24 | 10.60 | 10.14 | 10.37 | 10.52 | Upgrade
|
| PB Ratio | 9.51 | 11.35 | 11.69 | 11.35 | 11.25 | 10.26 | Upgrade
|
| P/TBV Ratio | 11.16 | 13.31 | 12.53 | 12.64 | 12.32 | 11.74 | Upgrade
|
| P/FCF Ratio | - | - | 166.48 | 95.23 | 109.98 | 271.61 | Upgrade
|
| P/OCF Ratio | - | - | 69.31 | 41.59 | 43.61 | 50.73 | Upgrade
|
| EV/Sales Ratio | 7.56 | 9.06 | 10.39 | 9.84 | 10.06 | 10.11 | Upgrade
|
| EV/EBITDA Ratio | 21.28 | 25.49 | 29.58 | 28.98 | 38.09 | 43.97 | Upgrade
|
| EV/EBIT Ratio | 22.29 | 26.70 | 31.46 | 31.32 | 42.66 | 51.64 | Upgrade
|
| EV/FCF Ratio | - | - | 163.28 | 92.42 | 106.67 | 260.99 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.00 | 0.00 | 0.01 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.11 | 0.11 | 0.01 | 0.01 | 0.02 | 0.10 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.05 | 0.04 | 0.07 | 0.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.26 | -0.35 | -0.40 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.52 | -0.52 | -0.66 | -0.93 | -1.39 | -1.75 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -3.64 | -2.96 | -3.90 | -10.41 | Upgrade
|
| Asset Turnover | - | - | 1.04 | 1.02 | 0.96 | 0.87 | Upgrade
|
| Inventory Turnover | - | - | 0.82 | 0.89 | 1.39 | 1.18 | Upgrade
|
| Quick Ratio | - | - | 3.55 | 2.80 | 3.04 | 4.01 | Upgrade
|
| Current Ratio | - | - | 4.34 | 3.32 | 3.57 | 4.71 | Upgrade
|
| Return on Equity (ROE) | 37.31% | 37.31% | 37.37% | 33.83% | 22.35% | 16.77% | Upgrade
|
| Return on Assets (ROA) | - | - | 21.51% | 19.99% | 14.09% | 10.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 47.49% | 52.26% | 53.10% | 55.56% | 37.47% | 29.64% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 35.40% | 33.80% | 24.00% | 17.80% | Upgrade
|
| Earnings Yield | 3.63% | 3.04% | 2.77% | 2.61% | 1.81% | 1.52% | Upgrade
|
| FCF Yield | - | - | 0.60% | 1.05% | 0.91% | 0.37% | Upgrade
|
| Dividend Yield | 0.87% | - | 0.85% | 0.80% | 0.56% | 0.35% | Upgrade
|
| Payout Ratio | - | - | 20.15% | 15.60% | 14.17% | 11.41% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | 0.18% | -0.56% | -0.29% | -0.39% | -0.18% | Upgrade
|
| Total Shareholder Return | 1.05% | 0.18% | 0.30% | 0.50% | 0.17% | 0.18% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.